The study demonstrates evolutionary conservation of SF3B1 phosphorylation for spliceosome activation, while identifying exploitable differences in ATP-binding pockets between trypanosome CRK9 and human CDK11.
CDK11-specific inhibition reveals SF3B1 phosphorylation as essential for spliceosome activation; extends mechanistic models of pre-mRNA splicing.
SF3B1 is a subunit of the heptameric SF3B complex which, as part of the U2 small nuclear ribonucleoprotein, facilitates branch point recognition in pre-mRNA splicing. In addition to this early-stage function, it was recently shown that activation of the spliceosome depends on the phosphorylation of threonine-proline (TP) motifs in the N-terminal domain (NTD) of SF3B1 by cyclin-dependent kinase 11 (CDK11). This breakthrough result was made possible by the discovery of the CDK11-specific inhibitor OTS964. Trypanosomes are protistan parasites whose proteomes are highly divergent in sequence from those of model organisms, and thus their CDKs were generically named CDC2-related kinases (CRKs). We previously characterized the trimeric CRK9 complex of Trypanosoma brucei and showed that it is essential for spliced leader trans splicing, the predominant splicing mode in the parasite. Although CRK9 and CDK11 deviate from each other substantially, we show that CRK9 activity is required to maintain SF3B1 phosphorylation in vivo, CRK9 directly phosphorylates TP motifs in the SF3B1 NTD in vitro, and the TP motifs themselves are crucial for spliceosome activation, demonstrating evolutionary conservation of this essential splicing step. Contrary to CDK11 and human cells, CRK9 and trypanosomes were rather insensitive to OTS964, indicating potentially exploitable differences in their ATP-binding pockets.
No takes yet. Share an insight, caveat, or question.
Machida et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: